Tempus Unveils New Whole-Genome Sequencing Assay
The whole-genome sequencing assay enhances precision medicine by identifying relevant genetic alterations in hematological malignancies.
Read MorePosted by Andy Lundin | Jan 15, 2025 | Hematology & Serology, Molecular Diagnostics |
The whole-genome sequencing assay enhances precision medicine by identifying relevant genetic alterations in hematological malignancies.
Read MorePosted by Chris Wolski | Dec 20, 2024 | Lung Cancer |
The results of AI-based classifiers for lung cancer using Qlucore Insights were recently presented by researchers.
Read MorePosted by Andy Lundin | Dec 16, 2024 | Leukemia |
Researchers developed a groundbreaking blood test to personalize nanomedicine therapies for leukemia patients, improving treatments.
Read MorePosted by Andy Lundin | Oct 22, 2024 | Lung Cancer, Molecular Diagnostics |
NeoGenomics received conditional approval from the New York State Department of Health for its Neo Comprehensive Solid Tumor and NeoTYPE DNA & RNA Lung assays.
Read MorePosted by Andy Lundin | Oct 9, 2024 | Leukemia |
Researchers have developed a CRISPR-based diagnostic test that accurately detects gene fusions in APL and CML within two hours.
Read More